ArticleESMO open2023

Longitudinal assessment of plasma androgen receptor copy number predicts overall survival in subsequent treatment lines in castration-resistant prostate cancer: analysis from a prospective trial.

N Brighi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.